GNLX
Price
$4.81
Change
-$0.01 (-0.21%)
Updated
Feb 21 closing price
Capitalization
166.13M
43 days until earnings call
UNCY
Price
$0.62
Change
+$0.01 (+1.64%)
Updated
Feb 21 closing price
Capitalization
64.03M
32 days until earnings call
Ad is loading...

GNLX vs UNCY

Header iconGNLX vs UNCY Comparison
Open Charts GNLX vs UNCYBanner chart's image
Genelux
Price$4.81
Change-$0.01 (-0.21%)
Volume$143.24K
Capitalization166.13M
Unicycive Therapeutics
Price$0.62
Change+$0.01 (+1.64%)
Volume$1.38M
Capitalization64.03M
GNLX vs UNCY Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. UNCY commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and UNCY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (GNLX: $4.81 vs. UNCY: $0.62)
Brand notoriety: GNLX and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 60% vs. UNCY: 124%
Market capitalization -- GNLX: $166.13M vs. UNCY: $64.03M
GNLX [@Biotechnology] is valued at $166.13M. UNCY’s [@Biotechnology] market capitalization is $64.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, UNCY is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 5 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • GNLX’s TA Score: 5 bullish, 5 bearish.
  • UNCY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than UNCY.

Price Growth

GNLX (@Biotechnology) experienced а -9.93% price change this week, while UNCY (@Biotechnology) price change was +4.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

GNLX is expected to report earnings on May 08, 2025.

UNCY is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($166M) has a higher market cap than UNCY($64M). GNLX YTD gains are higher at: 103.814 vs. UNCY (-22.324). UNCY has higher annual earnings (EBITDA): -22.56M vs. GNLX (-26.78M). GNLX has more cash in the bank: 34.1M vs. UNCY (32.3M). UNCY has less debt than GNLX: UNCY (807K) vs GNLX (2.04M). GNLX has higher revenues than UNCY: GNLX (8K) vs UNCY (0).
GNLXUNCYGNLX / UNCY
Capitalization166M64M259%
EBITDA-26.78M-22.56M119%
Gain YTD103.814-22.324-465%
P/E RatioN/AN/A-
Revenue8K0-
Total Cash34.1M32.3M106%
Total Debt2.04M807K253%
TECHNICAL ANALYSIS
Technical Analysis
GNLXUNCY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALDX6.69-0.03
-0.45%
Aldeyra Therapeutics
BEP23.44-0.14
-0.59%
Brookfield Renewable Partners LP
ZEPP2.97-0.02
-0.67%
Zepp Health Corporation
NBTB46.87-0.47
-0.99%
NBT Bancorp
SHOP115.56-7.91
-6.41%
Shopify

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-0.21%
VSTM - GNLX
46%
Loosely correlated
+1.97%
SNSE - GNLX
31%
Poorly correlated
-5.12%
ZLDAF - GNLX
26%
Poorly correlated
N/A
GNMSF - GNLX
26%
Poorly correlated
-0.59%
UNCY - GNLX
24%
Poorly correlated
+1.15%
More

UNCY and

Correlation & Price change

A.I.dvisor tells us that UNCY and BBIO have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UNCY and BBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+1.15%
BBIO - UNCY
32%
Poorly correlated
+0.12%
SCPX - UNCY
28%
Poorly correlated
+5.91%
SYRS - UNCY
26%
Poorly correlated
-0.85%
XNCR - UNCY
26%
Poorly correlated
-0.32%
ARWR - UNCY
25%
Poorly correlated
-5.06%
More